California First National Bancorp (NASDAQ:CFNB) hit a new 52-week high on Thursday . The stock traded as high as $15.09 and last traded at $14.95, with a volume of 11,713 shares traded. The stock had previously closed at $14.75.

Several equities research analysts have recently weighed in on CFNB shares. TheStreet raised shares of California First National Bancorp from a “hold” rating to a “buy” rating in a research report on Monday, May 9th. TD Securities cut shares of California First National Bancorp from a “buy” rating to a “hold” rating and increased their target price for the company from $24.00 to $27.00 in a research report on Tuesday, April 26th. Scotiabank reissued a “sector perform” rating and set a $28.00 target price (up previously from $27.00) on shares of California First National Bancorp in a research report on Sunday, May 1st. Finally, RBC Capital Markets cut shares of California First National Bancorp from a “sector perform” rating to an “underperform” rating and increased their target price for the company from $28.00 to $31.00 in a research report on Wednesday, July 20th. One investment analyst has rated the stock with a sell rating, five have given a hold rating and one has assigned a buy rating to the company’s stock. The stock has a consensus rating of “Hold” and a consensus price target of $27.00.

The company’s 50 day moving average price is $14.37 and its 200-day moving average price is $14.03. The stock has a market capitalization of $149.46 million and a P/E ratio of 17.52.

California First National Bancorp is a bank holding company. The Company operates through two business segments: CalFirst Leasing and CalFirst Bank. Its primary business is secured financing provided through leasing and financing capital assets, commercial loans acquired through participation in the syndicated commercial loan market, by providing non-recourse loans to third parties secured by leases and equipment, and direct commercial loans.

Get Analysts' Upgrades and Downgrades Daily - Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.